Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wainberg

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Retrovirology|December 3, 2015
World AIDS Day 2015Andrew Lever, Mark Wainberg
Drug Safety|June 20, 2003
Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concernsJulianna Lisziewicz, Andrea Foli, Mark Wainberg, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
EDITORIALNafsika H. Georgopapadakou, Henk Broxterman, Henry Chambers, et al.
Retrovirology|April 9, 2013
Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: landmark HIV-1 research honouredBen Berkhout, Andrew Lever, Mark Wainberg, et al.
Journal of the International AIDS Society|November 14, 2014
The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compoundMark Wainberg, Kaitlin Anstett, Thibault Mesplede, et al.
Journal of the International AIDS Society|November 14, 2014
Cenicriviroc blocks HIV entry but does not lead to redistribution of HIV into extracellular space like maravirocVictor Kramer, Said Hassounah, Susan Colby-Germinario, et al.
Journal of the International AIDS Society|November 15, 2014
HIV-1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV-1 group MAgnès Depatureaux, Thibault Mesplède, Peter Quashie, et al.
AIDS Research and Therapy|August 29, 2014
Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemicAlain Lafeuillade, Mark Wainberg, Marie-Lise Gougeon, et al.
Retrovirology|March 23, 2013
Obituary: Kuan-Teh JeangBen Berkhout, Monsef Benkirane, Andrew Lever, et al.
AIDS and Behavior|March 11, 2016
Beyond Condoms: Risk Reduction Strategies Among Gay, Bisexual, and Other Men Who Have Sex With Men Receiving Rapid HIV Testing in Montreal, CanadaJoanne Otis, Amélie McFadyen, Thomas Haig, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Retrovirology|December 3, 2015
World AIDS Day 2015Andrew Lever, Mark Wainberg
Drug Safety|June 20, 2003
Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concernsJulianna Lisziewicz, Andrea Foli, Mark Wainberg, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
EDITORIALNafsika H. Georgopapadakou, Henk Broxterman, Henry Chambers, et al.
Retrovirology|April 9, 2013
Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: landmark HIV-1 research honouredBen Berkhout, Andrew Lever, Mark Wainberg, et al.
Journal of the International AIDS Society|November 14, 2014
The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compoundMark Wainberg, Kaitlin Anstett, Thibault Mesplede, et al.
Journal of the International AIDS Society|November 14, 2014
Cenicriviroc blocks HIV entry but does not lead to redistribution of HIV into extracellular space like maravirocVictor Kramer, Said Hassounah, Susan Colby-Germinario, et al.
Journal of the International AIDS Society|November 15, 2014
HIV-1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV-1 group MAgnès Depatureaux, Thibault Mesplède, Peter Quashie, et al.
AIDS Research and Therapy|August 29, 2014
Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemicAlain Lafeuillade, Mark Wainberg, Marie-Lise Gougeon, et al.
Retrovirology|March 23, 2013
Obituary: Kuan-Teh JeangBen Berkhout, Monsef Benkirane, Andrew Lever, et al.
AIDS and Behavior|March 11, 2016
Beyond Condoms: Risk Reduction Strategies Among Gay, Bisexual, and Other Men Who Have Sex With Men Receiving Rapid HIV Testing in Montreal, CanadaJoanne Otis, Amélie McFadyen, Thomas Haig, et al.
Pageof 2